Drug Shortage Report for SEPTA-LOSARTAN
Report ID | 26238 |
Drug Identification Number | 02424975 |
Brand name | SEPTA-LOSARTAN |
Common or Proper name | Losartan 50 mg |
Company Name | SEPTA PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100s |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-10-05 |
Estimated end date | 2017-11-05 |
Actual end date | 2017-11-23 |
Shortage status | Resolved |
Updated date | 2017-11-24 |
Company comments | The drug shortage has been resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7035 MAXWELL ROAD, UNIT # 2 MISSISSAUGA, ONTARIO CANADA L5S 1R5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2017-11-24 | French | Compare |
v8 | 2017-11-24 | English | Compare |
v7 | 2017-11-24 | English | Compare |
v6 | 2017-11-24 | French | Compare |
v5 | 2017-11-24 | English | Compare |
v4 | 2017-10-18 | French | Compare |
v3 | 2017-10-18 | English | Compare |
v2 | 2017-10-18 | English | Compare |
v1 | 2017-10-18 | English | Compare |
Showing 1 to 9 of 9